Results 21 to 30 of about 582,852 (293)

PHOSPHATE BINDER THERAPY AND SERUM PHOSPHATE CONTROL FOLLOWING INITIATION OF HAEMODIALYSIS

open access: yesKidney Research and Clinical Practice, 2012
Hyperphosphataemia is associated with increased all-cause mortality in patients with chronic kidney disease (CKD), but serum phosphate (P) levels can be managed by dialysis, diet and the use of P binders. Serum P data were obtained retrospectively from a
Kimberly Farrand   +5 more
doaj   +1 more source

Scientific and Experimental Substantiation for the Production of Fireproof and Heat-Resistant Materials from Magnesia-Silicate Rocks

open access: yesJournal of Architectural and Engineering Research, 2022
Համառոտագիր Հոդվածը նվիրված է տեղական հումքով՝ Սևանի մագնեզիումասիլիկատային ապարներով, հրակայուն և կրակակայուն բետոնների ստացման տեխնոլոգիաների մշակմանը, որոնք կարող են օգտագործվել ջերմային ագրեգատներում՝ փոխարինելով շարվածքի մանրահատ աղյուսներին ու
Amalya Karapetyan, Maria Badalyan
doaj   +1 more source

FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER

open access: yesKidney Research and Clinical Practice, 2012
Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics.
T. Christopher Bond   +4 more
doaj   +1 more source

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease

open access: yesMicroorganisms, 2020
Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota.
Ping-Hsun Wu   +9 more
doaj   +1 more source

Enteral Ca-Intake May Be Low and Affects Serum-PTH-Levels in Pre-school Children With Chronic Kidney Disease

open access: yesFrontiers in Pediatrics, 2021
Treatment of chronic kidney disease (CKD) mineral bone disorder (MBD) is challenging in growing children due to the high amount of calcium needed for normal bone mineralization and the required dietary phosphate restriction, which often includes intake ...
Lilith Schmitz   +8 more
doaj   +1 more source

Sevelamer Carbonate Crystal-Induced Colitis

open access: yesCase Reports in Gastrointestinal Medicine, 2020
Hyperphosphatemia is a common and well-described complication of end-stage renal disease. Despite strict dietary constraints and compliance, phosphate binders such as calcium acetate and/or sevelamer carbonate are also needed to treat secondary ...
T. Lai   +3 more
doaj   +1 more source

The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence

open access: yes, 2013
Background: Phosphate binder medication adherence is required to maintain optimal phosphate levels and minimise bone disease in people with end stage kidney disease.Objectives: To examine the impact of a nurse‐led education intervention on bone disorder ...
Sandlin, K.   +3 more
core   +2 more sources

Comparison of sevelamer and calcium carbonate in prevention of hypomagnesemia in hemodialysis patients

open access: yesInternational Journal of Preventive Medicine, 2021
Background: Chronic kidney disease (CKD) is a life-threatening disease with numerous complications. Hemodialysis (HD) patients are prone to magnesium deficiency due to malnutrition, which can cause cardiovascular complications and increase mortality. The
Elahe Jandaghi   +5 more
doaj   +1 more source

Understanding the binder chemistry, microstructure, and physical properties of volcanic ash phosphate geopolymer binder

open access: yes, 2023
This work aims to assess the influence of the chemical composition of the binder resulting from the reaction of phosphoric acid and volcanic ash on its final characteristics. Six initial compositions of volcanic ash phosphate geopolymer with molar ratios
Stephan, Dietmar   +1 more
core   +1 more source

Colon Perforation in the Setting of Sevelamer Crystals

open access: yesAnnals of Internal Medicine: Clinical Cases, 2022
Sevelamer is frequently used as a phosphate binder in patients with end-stage renal disease. It can also cause gastrointestinal side effects including colitis, obstruction, and, rarely, perforation.
Gregory Shinaman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy